China Pharma Holdings (CPHI) Enterprise Value (2016 - 2025)
Historic Enterprise Value for China Pharma Holdings (CPHI) over the last 17 years, with Q3 2025 value amounting to -$300000.0.
- China Pharma Holdings' Enterprise Value rose 5825.74% to -$300000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$300000.0, marking a year-over-year increase of 5825.74%. This contributed to the annual value of -$626879.0 for FY2024, which is 5597.26% up from last year.
- Per China Pharma Holdings' latest filing, its Enterprise Value stood at -$300000.0 for Q3 2025, which was up 5825.74% from -$625032.0 recorded in Q2 2025.
- In the past 5 years, China Pharma Holdings' Enterprise Value registered a high of -$300000.0 during Q3 2025, and its lowest value of -$4.9 million during Q4 2021.
- Moreover, its 5-year median value for Enterprise Value was -$901910.0 (2023), whereas its average is -$1.4 million.
- As far as peak fluctuations go, China Pharma Holdings' Enterprise Value plummeted by 59496.75% in 2022, and later soared by 6858.66% in 2023.
- China Pharma Holdings' Enterprise Value (Quarter) stood at -$4.9 million in 2021, then soared by 58.22% to -$2.0 million in 2022, then grew by 29.86% to -$1.4 million in 2023, then surged by 55.97% to -$626879.0 in 2024, then skyrocketed by 52.14% to -$300000.0 in 2025.
- Its last three reported values are -$300000.0 in Q3 2025, -$625032.0 for Q2 2025, and -$412688.0 during Q1 2025.